20.86USDMkt Cap: 2.61B USDP/E: —Last update: 2026-05-22
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the trea…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap2.61B USD
Enterprise Value2.52B USD
Revenue (TTM)415.62M USD
Gross Profit339.38M USD
Net Income (TTM)-16.14M USD
Revenue/Share3.245 USD
Last Price20.86 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees354
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)18.18
PEG—
EV/EBITDA461.04
EV/Revenue6.06
P/S6.32
P/B13.85
EPS (TTM)-0.02
EPS (Forward)1.16
52W Range
20.6329% of range21.41
52W High21.41 USD
52W Low20.63 USD
Profitability
Gross Margin90.24%
Oper. Margin-8.62%
EBITDA Margin1.31%
Profit Margin-4.29%
ROE-8.52%
ROA-3.73%
Growth
Revenue Growth60.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.63M USD
CapEx (TTM)10.69M USD
FCF Margin0.85%
FCF Yield0.14%
Net Debt-109.33M USD
Net Debt/EBITDA-20.01
Balance Sheet
Debt/Equity0.60
Current Ratio2.68
Quick Ratio2.26
Book Value/Sh1.517 USD
Cash/Share1.791 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)34.63 USD
Target Range33.00 USD – 36.00 USD
# Analysts8
Ownership
Shares Out.125.08M
Float92.54M
Insiders1.76%
Institutions110.09%
Short Interest
Short Ratio15.3d
Short % Float14.39%
Short % Out.13.49%
Shares Short16.88M
Short (prev mo.)16.80M
Technical
SMA 5022.76 (-8.4%)
SMA 20023.31 (-10.5%)
Beta1.59
S&P 52W Chg28.31%
Avg Vol (30d)1.06M
Avg Vol (10d)2.52M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—